October 19, 2026
Volume Analysis | Flash Update – 10.19.26

Doji Know? Part III Looking back at last week’s field report, most regiments flashed dojis, signaling indecision and the potential for change in the trend or countertrend. The generals’ doji tested resistance near the highs, while much of the broader field’s dojis tested support near the lows. The candles looked alike, but their placement on […]

October 14, 2026
What Are Golden Handcuffs, and How Do Pharma Executives Get Trapped by Them? 

Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.